BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

31 filings reported holding 09061GAK7 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q3 2021.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 has 26 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $246,569,715 of principal .
Largest 10 bondholders include ADVENT CAPITAL MANAGEMENT /DE/ ($70,371,000 of principal), MACKAY SHIELDS LLC ($36,500,000 of principal), CNH PARTNERS LLC ($21,650,000 of principal), SHENKMAN CAPITAL MANAGEMENT INC ($18,021,000 of principal), STATE STREET CORP ($17,566,000 of principal), Thrivent Financial for Lutherans ($16,000,000 of principal), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ($15,700,000 of principal), LAZARD ASSET MANAGEMENT LLC ($13,595,000 of principal), DEUTSCHE BANK AG\ ($10,971,000 of principal), and NEW YORK STATE COMMON RETIREMENT FUND ($7,593,000 of principal).
This table shows the top 26 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.